Search Results for 'dyadic'

Dyadic to develop Bakenzyme enzyme for baking industry

In Florida, Dyadic has announced details regarding its new Bakenzyme project. In collaboration with several industry partners, the Bakenzyme project seeks to develop a novel, pure and widely applicable xylanase-oxidase enzyme product for the baking industry. Dyadic’s Chief Operating Officer, Danai Brooks, stated, “The aim of this project is to create an enzyme product that improves […]

July 14, 2014 More

Dyadic rocks Q1– gross profits double, revenue up 20%

In Florida, Dyadic’s gross profit in Q1 of FY2014 has nearly doubled from $520,000 to over $1,000,000 since FY2013, according to the company’s Q1 results announced last week. Revenues also grew 20% in Q1. Regarding the coming months, CEO Mark Emalfarb said, “Dyadic’s technology licensing model is expected to bring us recurring royalty streams in […]

May 12, 2014 More

Dyadic launches Fibrezyme G4 enzyme for pulp industry

In Florida, Dyadic has announced that it has launched Fibrezyme G4, a high performance cellulase enzyme product designed to enhance paper and textile quality. The enzyme has shown to reduce energy requirements and increase production rates for pulp and paper manufacturers. Dyadic Chief Operating Officer Danai Brooks commented: “We expect two key markets to be […]

April 27, 2014 More

Dyadic gets patent for C-1 enzyme technology

In the Netherlands, Dyadic has received a US patent for its C-1 technology that is currently being implemented at Abengoa’s cellulosic ethanol plant that’s getting read to start up in Hugoton, Kan. As Abengoa goes to license its technology package, Dyadic’s C-1 would be the enzyme component. The patent is Dyadic’s 14th.

March 27, 2014 More

Dyadic: Biofuels Digest’s 2014 5-Minute Guide

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries. Rankings 50 Hottest Companies in Bioenergy: 2013/14, #46 The Situation In their 2013 results, […]

March 18, 2014 More

Dyadic announces 10% gains on revenue in FY2013 financial results

In Florida, Dyadic International has announced their financial results for the FY2013. Total revenue for the company increased 10% for the year compared to FY2012, with net product-related revenue increasing 25% to $9.8 million. The increase was driven primarily by increases in the animal health and nutrition segments, the addition of two major customers and […]

March 16, 2014 More

Dyadic: Transformative Technologies 2014 nominee, “Transformative Enzyme”

This is the official Transformative Technologies 2014 nominee page for Dyadic, nominated in the “Transformative Enzyme or organic catalyst” category for its C1 expression system. Voting Rules All voting is exclusively via social media this year. To vote, simply click on the Tweet, Like or Share link in on this page. Each tweet, like or share […]

March 9, 2014 More

Dyadic International finishes major lab expansion in the Netherlands

In Florida, Dyadic International, Inc. announced that the expansion of its research laboratory in The Netherlands is now complete. Floor space at Dyadic Netherlands has significantly increased allowing for the installation of a wide range of state-of-the-art research equipment including a new fermentation lab. In addition, the expansion will facilitate the housing of new scientists […]

January 30, 2014 More

Dyadic reports on Q3 2013 and first nine months of 2013

In Florida, Dyadic International reports that during the third quarter of 2013, the Company recognized a loss of $313,000 on settlement of litigation, while net income for the nine months was $121,000, compared to a net income of $2.8 million for the same period a year ago. Dyadic reports that for the 2013 full-year outlook, […]

November 20, 2013 More

Dyadic lands key cellulosic biofuels patent

In Florida, Dyadic (OTC Pink: DYAI) announced that it has been issued U.S. Patent No. 8,551,751 B2 entitled, “BX11 Enzymes Having Xylosidase Activity” by the United States Patent and Trademark Office (“USPTO”). The invention relates to methods of developing and producing novel enzymes, more specifically for the development of a variety of fungal enzymes. In addition, […]

November 11, 2013 More